Five-Year Incidence of Visual Impairment in Middle-Aged Iranians: The Shahroud Eye Cohort Study

Purpose: To study the 5-year incidence of visual impairment and its causes and risk factors, in the middle-aged Iranian sample of the Shahroud Eye Cohort Study (ShECS). Methods: Data from subjects who had participated in both phases of the ShECS were used to determine age- and sex-specific incidence...

Full description

Saved in:
Bibliographic Details
Published inOphthalmic epidemiology Vol. 24; no. 1; pp. 11 - 16
Main Authors Hashemi, Hassan, Mehravaran, Shiva, Emamian, Mohammad Hassan, Fotouhi, Akbar
Format Journal Article
LanguageEnglish
Published England Taylor & Francis 01.02.2017
Subjects
Online AccessGet full text

Cover

Loading…
Abstract Purpose: To study the 5-year incidence of visual impairment and its causes and risk factors, in the middle-aged Iranian sample of the Shahroud Eye Cohort Study (ShECS). Methods: Data from subjects who had participated in both phases of the ShECS were used to determine age- and sex-specific incidence rates of visual impairment using the World Health Organization (WHO) definitions for bilateral low vision (visual acuity, VA, >0.5 and ≤1.3 LogMAR in the better eye) and blindness (VA worse than 1.3 LogMAR in the better eye). Risk ratios (RR) and 95% confidence intervals (CIs) were calculated using multivariable log-binomial regression. Results: Of the 5079 ShECS I survivors, 4737 (93.3%) completed the 5-year follow-up. Their mean age at baseline was 50.9 ± 6.2 years, and 58.9% were female. The incidence of visual impairment was 1.12% (95% CI 0.82-1.42%) by presenting VA and 0.19% (95% CI 0.07-0.32%) by best-corrected VA; leading causes of the former were uncorrected refractive error (81.3%) and diabetic retinopathy (15.1%). In the multivariable model, risk factors for incident visual impairment by presenting VA were older age (RR 1.05, p = 0.044), lower education (RR 0.89, p = 0.002), and diabetes (RR 3.74, p < 0.001). Conclusion: This is the first incidence study of visual impairment in a middle-aged Iranian population. Since age is a major risk factor, the number of visually impaired is expected to increase as the population ages, and less treatable causes such as diabetic retinopathy begin to surface. Measures for tackling uncorrected refractive error and enhancing diabetes screening and preventive programs are recommended.
AbstractList To study the 5-year incidence of visual impairment and its causes and risk factors, in the middle-aged Iranian sample of the Shahroud Eye Cohort Study (ShECS).PURPOSETo study the 5-year incidence of visual impairment and its causes and risk factors, in the middle-aged Iranian sample of the Shahroud Eye Cohort Study (ShECS).Data from subjects who had participated in both phases of the ShECS were used to determine age- and sex-specific incidence rates of visual impairment using the World Health Organization (WHO) definitions for bilateral low vision (visual acuity, VA, >0.5 and ≤1.3 LogMAR in the better eye) and blindness (VA worse than 1.3 LogMAR in the better eye). Risk ratios (RR) and 95% confidence intervals (CIs) were calculated using multivariable log-binomial regression.METHODSData from subjects who had participated in both phases of the ShECS were used to determine age- and sex-specific incidence rates of visual impairment using the World Health Organization (WHO) definitions for bilateral low vision (visual acuity, VA, >0.5 and ≤1.3 LogMAR in the better eye) and blindness (VA worse than 1.3 LogMAR in the better eye). Risk ratios (RR) and 95% confidence intervals (CIs) were calculated using multivariable log-binomial regression.Of the 5079 ShECS I survivors, 4737 (93.3%) completed the 5-year follow-up. Their mean age at baseline was 50.9 ± 6.2 years, and 58.9% were female. The incidence of visual impairment was 1.12% (95% CI 0.82-1.42%) by presenting VA and 0.19% (95% CI 0.07-0.32%) by best-corrected VA; leading causes of the former were uncorrected refractive error (81.3%) and diabetic retinopathy (15.1%). In the multivariable model, risk factors for incident visual impairment by presenting VA were older age (RR 1.05, p = 0.044), lower education (RR 0.89, p = 0.002), and diabetes (RR 3.74, p < 0.001).RESULTSOf the 5079 ShECS I survivors, 4737 (93.3%) completed the 5-year follow-up. Their mean age at baseline was 50.9 ± 6.2 years, and 58.9% were female. The incidence of visual impairment was 1.12% (95% CI 0.82-1.42%) by presenting VA and 0.19% (95% CI 0.07-0.32%) by best-corrected VA; leading causes of the former were uncorrected refractive error (81.3%) and diabetic retinopathy (15.1%). In the multivariable model, risk factors for incident visual impairment by presenting VA were older age (RR 1.05, p = 0.044), lower education (RR 0.89, p = 0.002), and diabetes (RR 3.74, p < 0.001).This is the first incidence study of visual impairment in a middle-aged Iranian population. Since age is a major risk factor, the number of visually impaired is expected to increase as the population ages, and less treatable causes such as diabetic retinopathy begin to surface. Measures for tackling uncorrected refractive error and enhancing diabetes screening and preventive programs are recommended.CONCLUSIONThis is the first incidence study of visual impairment in a middle-aged Iranian population. Since age is a major risk factor, the number of visually impaired is expected to increase as the population ages, and less treatable causes such as diabetic retinopathy begin to surface. Measures for tackling uncorrected refractive error and enhancing diabetes screening and preventive programs are recommended.
To study the 5-year incidence of visual impairment and its causes and risk factors, in the middle-aged Iranian sample of the Shahroud Eye Cohort Study (ShECS). Data from subjects who had participated in both phases of the ShECS were used to determine age- and sex-specific incidence rates of visual impairment using the World Health Organization (WHO) definitions for bilateral low vision (visual acuity, VA, >0.5 and ≤1.3 LogMAR in the better eye) and blindness (VA worse than 1.3 LogMAR in the better eye). Risk ratios (RR) and 95% confidence intervals (CIs) were calculated using multivariable log-binomial regression. Of the 5079 ShECS I survivors, 4737 (93.3%) completed the 5-year follow-up. Their mean age at baseline was 50.9 ± 6.2 years, and 58.9% were female. The incidence of visual impairment was 1.12% (95% CI 0.82-1.42%) by presenting VA and 0.19% (95% CI 0.07-0.32%) by best-corrected VA; leading causes of the former were uncorrected refractive error (81.3%) and diabetic retinopathy (15.1%). In the multivariable model, risk factors for incident visual impairment by presenting VA were older age (RR 1.05, p = 0.044), lower education (RR 0.89, p = 0.002), and diabetes (RR 3.74, p < 0.001). This is the first incidence study of visual impairment in a middle-aged Iranian population. Since age is a major risk factor, the number of visually impaired is expected to increase as the population ages, and less treatable causes such as diabetic retinopathy begin to surface. Measures for tackling uncorrected refractive error and enhancing diabetes screening and preventive programs are recommended.
Purpose: To study the 5-year incidence of visual impairment and its causes and risk factors, in the middle-aged Iranian sample of the Shahroud Eye Cohort Study (ShECS). Methods: Data from subjects who had participated in both phases of the ShECS were used to determine age- and sex-specific incidence rates of visual impairment using the World Health Organization (WHO) definitions for bilateral low vision (visual acuity, VA, >0.5 and ≤1.3 LogMAR in the better eye) and blindness (VA worse than 1.3 LogMAR in the better eye). Risk ratios (RR) and 95% confidence intervals (CIs) were calculated using multivariable log-binomial regression. Results: Of the 5079 ShECS I survivors, 4737 (93.3%) completed the 5-year follow-up. Their mean age at baseline was 50.9 ± 6.2 years, and 58.9% were female. The incidence of visual impairment was 1.12% (95% CI 0.82-1.42%) by presenting VA and 0.19% (95% CI 0.07-0.32%) by best-corrected VA; leading causes of the former were uncorrected refractive error (81.3%) and diabetic retinopathy (15.1%). In the multivariable model, risk factors for incident visual impairment by presenting VA were older age (RR 1.05, p = 0.044), lower education (RR 0.89, p = 0.002), and diabetes (RR 3.74, p < 0.001). Conclusion: This is the first incidence study of visual impairment in a middle-aged Iranian population. Since age is a major risk factor, the number of visually impaired is expected to increase as the population ages, and less treatable causes such as diabetic retinopathy begin to surface. Measures for tackling uncorrected refractive error and enhancing diabetes screening and preventive programs are recommended.
Author Mehravaran, Shiva
Hashemi, Hassan
Emamian, Mohammad Hassan
Fotouhi, Akbar
Author_xml – sequence: 1
  givenname: Hassan
  surname: Hashemi
  fullname: Hashemi, Hassan
  organization: Noor Ophthalmology Research Center, Noor Eye Hospital
– sequence: 2
  givenname: Shiva
  surname: Mehravaran
  fullname: Mehravaran, Shiva
  organization: Noor Ophthalmology Research Center, Noor Eye Hospital
– sequence: 3
  givenname: Mohammad Hassan
  surname: Emamian
  fullname: Emamian, Mohammad Hassan
  organization: Department of Epidemiology, School of Public Health, Shahroud University of Medical Sciences
– sequence: 4
  givenname: Akbar
  surname: Fotouhi
  fullname: Fotouhi, Akbar
  email: afotouhi@tums.ac.ir
  organization: Department of Epidemiology and Biostatistics, School of Public Health, Tehran University of Medical Sciences
BackLink https://www.ncbi.nlm.nih.gov/pubmed/27960616$$D View this record in MEDLINE/PubMed
BookMark eNqFkU1vGyEQhlGUKHE-fkIqjr2sA8vC4vTSyEoaS6l6SFKpJ4RhqIl2wQW2lf9917J96aE5zeV53hnNe46OQwyA0DUlU0okuSGzWgouxbQmVExpzTlr6iM0oW3TVJxIcYwmW6baQmfoPOc3QqgkXJyis7qdCSKomCD14H9D9QN0wotgvIVgAEeHv_s86A4v-rX2qYdQsA_4q7e2g-ruJ1i8SDp4HfItflkBfl7pVYqDxfcbwPO4iqng5zLYzSU6cbrLcLWfF-j14f5l_lg9ffuymN89VYYJUSo2a4G58SiwTnPhpBNUc4CG8JqL2hgCZtYysqQjzrlpGqIl1ZQuwRFpGLtAH3e56xR_DZCL6n020HU6QByyopLXoqUt4yP6YY8Oyx6sWiff67RRh6eMwKcdYFLMOYFTxhddfAwlad8pStS2AnWoQG0rUPsKRpv_Yx8WvOd93nk-uJh6_SemzqqiN11Mbny28Vmx_0f8BRKRmzI
CitedBy_id crossref_primary_10_1111_ceo_13431
crossref_primary_10_1016_j_xops_2023_100392
crossref_primary_10_1016_j_ijnss_2023_06_010
crossref_primary_10_1016_j_jdiacomp_2020_107560
crossref_primary_10_15171_ijhpm_2017_48
crossref_primary_10_1136_bjophthalmol_2021_320892
crossref_primary_10_1016_j_ajo_2020_09_035
Cites_doi 10.1001/archopht.120.5.613
10.1016/j.ophtha.2012.11.041
10.1016/S0161-6420(01)00769-2
10.1111/1753-0407.12195
10.1016/S0039-6257(05)80092-X
10.1038/eye.2012.94
10.1167/iovs.13-11911
10.1136/bjo.86.2.238
10.1093/ije/dys161
10.1111/j.1755-3768.2008.01445.x
10.1016/S0161-6420(02)01898-5
10.1016/j.ophtha.2013.03.032
10.1016/j.ophtha.2010.09.032
10.1167/iovs.02-0457
10.1016/S0161-6420(02)01295-2
ContentType Journal Article
Copyright 2017 Taylor & Francis Group, LLC 2017
Copyright_xml – notice: 2017 Taylor & Francis Group, LLC 2017
DBID AAYXX
CITATION
CGR
CUY
CVF
ECM
EIF
NPM
7X8
DOI 10.1080/09286586.2016.1255342
DatabaseName CrossRef
Medline
MEDLINE
MEDLINE (Ovid)
MEDLINE
MEDLINE
PubMed
MEDLINE - Academic
DatabaseTitle CrossRef
MEDLINE
Medline Complete
MEDLINE with Full Text
PubMed
MEDLINE (Ovid)
MEDLINE - Academic
DatabaseTitleList MEDLINE - Academic
MEDLINE

Database_xml – sequence: 1
  dbid: NPM
  name: PubMed
  url: https://proxy.k.utb.cz/login?url=http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed
  sourceTypes: Index Database
– sequence: 2
  dbid: EIF
  name: MEDLINE
  url: https://proxy.k.utb.cz/login?url=https://www.webofscience.com/wos/medline/basic-search
  sourceTypes: Index Database
DeliveryMethod fulltext_linktorsrc
Discipline Medicine
EISSN 1744-5086
EndPage 16
ExternalDocumentID 27960616
10_1080_09286586_2016_1255342
1255342
Genre Article
Research Support, Non-U.S. Gov't
Journal Article
GrantInformation_xml – fundername: Shahroud University of Medical Sciences
– fundername: Noor Ophthalmology Research Center
GroupedDBID ---
00X
03L
0BK
0R~
123
29N
36B
4.4
53G
AALUX
AAMIU
AAPUL
AAPXX
AAQRR
ABBKH
ABDBF
ABEIZ
ABJNI
ABLIJ
ABLKL
ABUPF
ABXYU
ACENM
ACGEJ
ACGFS
ACIEZ
ACUHS
ADCVX
ADRBQ
ADXPE
AECIN
AENEX
AEOZL
AFKVX
AGDLA
AGFJD
AGRBW
AGYJP
AIJEM
AIRBT
AJWEG
AKBVH
ALMA_UNASSIGNED_HOLDINGS
ALQZU
ALYBC
AMDAE
BABNJ
BLEHA
BOHLJ
CCCUG
CS3
DKSSO
DU5
EAP
EBC
EBD
EBS
EJD
EMB
EMK
EMOBN
EPL
ESX
F5P
H13
HZ~
KRBQP
KSSTO
KWAYT
KYCEM
M4Z
O9-
P2P
RNANH
RVRKI
SV3
TBQAZ
TDBHL
TERGH
TFDNU
TFL
TFW
TUROJ
TUS
UEQFS
V1S
~1N
AAGDL
AAYXX
ABWVI
ADYSH
AFRVT
AMPGV
CITATION
5VS
AALIY
AAORF
ABWCV
ABZEW
ACKZS
ADFOM
ADFZZ
AEIIZ
AFFVI
AFLEI
AJVHN
AWYRJ
BRMBE
CAG
CGR
COF
CUY
CVF
CYYVM
CZDIS
DRXRE
DWTOO
ECM
EIF
JENTW
LJTGL
M44
NPM
NUSFT
QQXMO
S70
7X8
TASJS
ID FETCH-LOGICAL-c366t-397e3f960edfa56f8f61a5ee4052562cc0ec9730b136655c440a81a11bef08c33
ISSN 0928-6586
1744-5086
IngestDate Sun Aug 24 04:21:41 EDT 2025
Wed Feb 19 02:40:54 EST 2025
Thu Apr 24 23:08:13 EDT 2025
Tue Jul 01 00:45:41 EDT 2025
Wed Dec 25 09:04:57 EST 2024
IsPeerReviewed true
IsScholarly true
Issue 1
Keywords visual impairment
Iran
longitudinal
incidence
Blindness
Language English
LinkModel OpenURL
MergedId FETCHMERGED-LOGICAL-c366t-397e3f960edfa56f8f61a5ee4052562cc0ec9730b136655c440a81a11bef08c33
Notes ObjectType-Article-1
SourceType-Scholarly Journals-1
ObjectType-Feature-2
content type line 23
PMID 27960616
PQID 1852671735
PQPubID 23479
PageCount 6
ParticipantIDs informaworld_taylorfrancis_310_1080_09286586_2016_1255342
crossref_citationtrail_10_1080_09286586_2016_1255342
crossref_primary_10_1080_09286586_2016_1255342
proquest_miscellaneous_1852671735
pubmed_primary_27960616
ProviderPackageCode CITATION
AAYXX
PublicationCentury 2000
PublicationDate 2017-02-01
PublicationDateYYYYMMDD 2017-02-01
PublicationDate_xml – month: 02
  year: 2017
  text: 2017-02-01
  day: 01
PublicationDecade 2010
PublicationPlace England
PublicationPlace_xml – name: England
PublicationTitle Ophthalmic epidemiology
PublicationTitleAlternate Ophthalmic Epidemiol
PublicationYear 2017
Publisher Taylor & Francis
Publisher_xml – name: Taylor & Francis
References Leske MC (CIT0020) 2010; 27
Yonekawa Y (CIT0017) 1790; 2011
CIT0010
CIT0021
Congdon N (CIT0018) 2004; 122
CIT0012
CIT0011
CIT0022
Leske MC (CIT0014) 2004; 111
Early Treatment Diabetic Retinopathy Study Research Group (CIT0005) 1991; 98
CIT0003
CIT0002
CIT0013
CIT0016
CIT0015
CIT0007
CIT0006
CIT0009
Congdon N (CIT0004) 2001; 42
CIT0008
CIT0019
References_xml – ident: CIT0016
  doi: 10.1001/archopht.120.5.613
– ident: CIT0019
  doi: 10.1016/j.ophtha.2012.11.041
– ident: CIT0021
  doi: 10.1016/S0161-6420(01)00769-2
– volume: 27
  start-page: 259
  year: 2010
  ident: CIT0020
  publication-title: Causes of visual loss and their risk factors: an incidence summary from the Barbados Eye Studies. Rev Panam Salud Publica
– ident: CIT0022
  doi: 10.1111/1753-0407.12195
– ident: CIT0007
  doi: 10.1016/S0039-6257(05)80092-X
– ident: CIT0003
  doi: 10.1038/eye.2012.94
– ident: CIT0008
  doi: 10.1167/iovs.13-11911
– ident: CIT0006
  doi: 10.1136/bjo.86.2.238
– ident: CIT0002
  doi: 10.1093/ije/dys161
– ident: CIT0009
  doi: 10.1111/j.1755-3768.2008.01445.x
– volume: 2011
  issue: 118
  year: 1790
  ident: CIT0017
  publication-title: Ophthalmology
– volume: 122
  start-page: 487
  year: 2004
  ident: CIT0018
  publication-title: Prevalence of cataract and pseudophakia/aphakia among adults in the United States. Arch Ophthalmol
– volume: 111
  start-page: 118
  year: 2004
  ident: CIT0014
  publication-title: Four-year incidence of visual impairment: Barbados Incidence Study of Eye Diseases. Ophthalmology
– ident: CIT0013
  doi: 10.1016/S0161-6420(02)01898-5
– volume: 42
  start-page: 2478
  year: 2001
  ident: CIT0004
  publication-title: Invest Ophthalmol Vis Sci
– volume: 98
  start-page: 786
  year: 1991
  ident: CIT0005
  publication-title: Grading diabetic retinopathy from stereoscopic color fundus photographs – an extension of the modified Airlie House classification
– ident: CIT0015
  doi: 10.1016/j.ophtha.2013.03.032
– ident: CIT0010
  doi: 10.1016/j.ophtha.2010.09.032
– ident: CIT0011
  doi: 10.1167/iovs.02-0457
– ident: CIT0012
  doi: 10.1016/S0161-6420(02)01295-2
SSID ssj0018056
Score 2.161539
Snippet Purpose: To study the 5-year incidence of visual impairment and its causes and risk factors, in the middle-aged Iranian sample of the Shahroud Eye Cohort Study...
To study the 5-year incidence of visual impairment and its causes and risk factors, in the middle-aged Iranian sample of the Shahroud Eye Cohort Study (ShECS)....
To study the 5-year incidence of visual impairment and its causes and risk factors, in the middle-aged Iranian sample of the Shahroud Eye Cohort Study...
SourceID proquest
pubmed
crossref
informaworld
SourceType Aggregation Database
Index Database
Enrichment Source
Publisher
StartPage 11
SubjectTerms Adult
Age Distribution
Aged
Aged, 80 and over
Blindness
Blindness - epidemiology
Cohort Studies
Female
Humans
Incidence
Iran
Iran - epidemiology
longitudinal
Male
Middle Aged
Multivariate Analysis
Risk Factors
Sex Distribution
Vision, Low - epidemiology
Visual Acuity
visual impairment
Title Five-Year Incidence of Visual Impairment in Middle-Aged Iranians: The Shahroud Eye Cohort Study
URI https://www.tandfonline.com/doi/abs/10.1080/09286586.2016.1255342
https://www.ncbi.nlm.nih.gov/pubmed/27960616
https://www.proquest.com/docview/1852671735
Volume 24
hasFullText 1
inHoldings 1
isFullTextHit
isPrint
link http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwpV1bb9MwFLbKJiFeEHc2LjISb1WquIndZG8dtNqQAg90aDxFjuOQiDWZ0nTS-B_8X45j57YNjctLVDl1k_p8PuezfS4IvWUkdmIWM4vA3IEFCuWWx_zISgBdXmLb0qYq3jn4yI5O3A-n9HQ0-tnzWtpW0UT8uDGu5F-kCm0gVxUl-xeSbX8UGuAzyBeuIGG4_pGMl6CqrK8qFQ9Mc10dVJG_L9lGBYUcw0zPyvqwP8vHQb0TYc2_AcM8BgOVKQZtXC4-p1yV64nHi0tVxS4FSl47GA6OfD-dp1XKz5QvvezKyl52Kmyjcg_UpgwIeQe6QKYlv-Cl2WlNs4vWEizWfJ3p9qBI-XrN4yudl0VVbOu6w-P594iX_U0KMHz2wOFjda1eSH8jcupZwINMQmythmeuawF1ZH09rWOtB3jUStdoa22-deTmNcNgPCl9FYjrKdcUwibA7aijc3tdyblt7txBu1NYfYD63J0fvj9ctsdTnl2XBW5fvQkNU0nbb3rEgPQMUuL-fmFTE5zVA3TfrEzwXMPsIRrJ_BG6Gxjfi8cobNGGW7ThIsEabbhDG85y3EMbbtB2gAFruMEaBqxhjTVcY-0JOlkuVu-OLFOewxIOY5UFTFY6CayAZZxwyhIvYYRTKV1VGpFNhbCl8MGARAS-TqlwXZt7hBMSycT2hOM8RTt5kcvnCDu-zfzEk5GYETemJIqiOBYzWEtRb0oF3UNuM36hMLnrVQmVs5A0KW7NsIdq2EMz7Hto0nY718lbbuvg94UTVjVuEw3Z0Lml75tGkiGoaHXuxnNZbDehyk_AlLcL_I9nWsTt60xnaguBsP3_ePILdK-bcy_RTlVu5SugylX02gD3F8BLtYM
linkProvider EBSCOhost
openUrl ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=Five-Year+Incidence+of+Visual+Impairment+in+Middle-Aged+Iranians%3A+The+Shahroud+Eye+Cohort+Study&rft.jtitle=Ophthalmic+epidemiology&rft.au=Hashemi%2C+Hassan&rft.au=Mehravaran%2C+Shiva&rft.au=Emamian%2C+Mohammad+Hassan&rft.au=Fotouhi%2C+Akbar&rft.date=2017-02-01&rft.pub=Taylor+%26+Francis&rft.issn=0928-6586&rft.eissn=1744-5086&rft.volume=24&rft.issue=1&rft.spage=11&rft.epage=16&rft_id=info:doi/10.1080%2F09286586.2016.1255342&rft.externalDocID=1255342
thumbnail_l http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=0928-6586&client=summon
thumbnail_m http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=0928-6586&client=summon
thumbnail_s http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=0928-6586&client=summon